Product Information

POTASSIUM CL ER 10 MEQ TABLET is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1296 per EA under NDC 68462047101. Its NADAC has been published 488 times since Apr 19, 2017.

FDA first approved this application on Jul 26, 2016. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

POTASSIUM CL ER 10 MEQ TABLET

potassium chloride
$0.1296per EA

Strength

750 mg/1

NDC

68462047101

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA203562

FDA Approved

7/26/2016

TE Code

AB1

On Market Since

7/26/2016

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POTASSIUM CL ER 10 MEQ TABLET has been published 488 times since Apr 19, 2017, and over the history we have for it it has declined 47.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1296 per EA
All-time high$0.3080 (Jan 15, 2020)
All-time low$0.0902 (Jul 17, 2024)
52-week high$0.1380
52-week low$0.1186
Median price$0.2071
Average price$0.2022
Largest weekly change+61.7% (Jun 19, 2024)
Weeks tracked488
Tracking sinceApr 19, 2017

Price History

1W

+1.2%

1M

+1.2%

3M

-6.1%

6M

-2.6%

1Y

-1.1%

3Y

-19.5%

5Y

-48.7%

All

-47.8%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 35% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of POTASSIUM CL ER 10 MEQ TABLET?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 10 MEQ TABLET, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1296 per EA (NDC 68462047101), effective Aug 19, 2026.

How has the price of POTASSIUM CL ER 10 MEQ TABLET changed over time?

Over the history we have for it, the NADAC for POTASSIUM CL ER 10 MEQ TABLET has declined 47.8%. It has been tracked across 488 weekly CMS publications since Apr 19, 2017.

What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 10 MEQ TABLET?

Since Apr 19, 2017, the NADAC for POTASSIUM CL ER 10 MEQ TABLET has ranged from a low of $0.0902 (Jul 17, 2024) to a high of $0.3080 (Jan 15, 2020), with a median of $0.2071 per EA.

Are there cheaper alternatives to POTASSIUM CL ER 10 MEQ TABLET?

Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL ER 10 MEQ TABLET, is $0.0838 per EA — about 35% below POTASSIUM CL ER 10 MEQ TABLET.

Who manufactures POTASSIUM CL ER 10 MEQ TABLET?

POTASSIUM CL ER 10 MEQ TABLET (NDC 68462047101) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.